208 related articles for article (PubMed ID: 38159863)
21. Agonists and antagonists of protease activated receptors (PARs).
Barry GD; Le GT; Fairlie DP
Curr Med Chem; 2006; 13(3):243-65. PubMed ID: 16475935
[TBL] [Abstract][Full Text] [Related]
22. [Development of agonists/antagonists for protease-activated receptors (PARs) and the possible therapeutic application to gastrointestinal diseases].
Sekiguchi F
Yakugaku Zasshi; 2005 Jun; 125(6):491-8. PubMed ID: 15930817
[TBL] [Abstract][Full Text] [Related]
23. The Yin-Yang roles of protease-activated receptors in inflammatory signalling and diseases.
Zhuo X; Wu Y; Fu X; Liang X; Xiang Y; Li J; Mao C; Jiang Y
FEBS J; 2022 Jul; 289(14):4000-4020. PubMed ID: 35175692
[TBL] [Abstract][Full Text] [Related]
24. Protease-activated receptors in hemostasis, thrombosis and vascular biology.
Coughlin SR
J Thromb Haemost; 2005 Aug; 3(8):1800-14. PubMed ID: 16102047
[TBL] [Abstract][Full Text] [Related]
25. GPCRs in Cancer: Protease-Activated Receptors, Endocytic Adaptors and Signaling.
Arakaki AKS; Pan WA; Trejo J
Int J Mol Sci; 2018 Jun; 19(7):. PubMed ID: 29954076
[TBL] [Abstract][Full Text] [Related]
26. Allosteric modulation of protease-activated receptor signaling.
Canto I; Soh UJ; Trejo J
Mini Rev Med Chem; 2012 Aug; 12(9):804-11. PubMed ID: 22681248
[TBL] [Abstract][Full Text] [Related]
27. Proteinases and signalling: pathophysiological and therapeutic implications via PARs and more.
Ramachandran R; Hollenberg MD
Br J Pharmacol; 2008 Mar; 153 Suppl 1(Suppl 1):S263-82. PubMed ID: 18059329
[TBL] [Abstract][Full Text] [Related]
28. Targeting proteinase-activated receptors: therapeutic potential and challenges.
Ramachandran R; Noorbakhsh F; Defea K; Hollenberg MD
Nat Rev Drug Discov; 2012 Jan; 11(1):69-86. PubMed ID: 22212680
[TBL] [Abstract][Full Text] [Related]
29. Challenges and Opportunities in Protease-Activated Receptor Drug Development.
Hamilton JR; Trejo J
Annu Rev Pharmacol Toxicol; 2017 Jan; 57():349-373. PubMed ID: 27618736
[TBL] [Abstract][Full Text] [Related]
30. Proteinase-activated receptors: transducers of proteinase-mediated signaling in inflammation and immune response.
Steinhoff M; Buddenkotte J; Shpacovitch V; Rattenholl A; Moormann C; Vergnolle N; Luger TA; Hollenberg MD
Endocr Rev; 2005 Feb; 26(1):1-43. PubMed ID: 15689571
[TBL] [Abstract][Full Text] [Related]
31. Modulation of visceral pain and inflammation by protease-activated receptors.
Vergnolle N
Br J Pharmacol; 2004 Apr; 141(8):1264-74. PubMed ID: 15051630
[TBL] [Abstract][Full Text] [Related]
32. Proteinase-activated receptors (PARs) as targets for antiplatelet therapy.
Cunningham M; McIntosh K; Bushell T; Sloan G; Plevin R
Biochem Soc Trans; 2016 Apr; 44(2):606-12. PubMed ID: 27068977
[TBL] [Abstract][Full Text] [Related]
33. Proteinase-activated receptors in the lower urinary tract.
Moffatt JD
Naunyn Schmiedebergs Arch Pharmacol; 2007 Mar; 375(1):1-9. PubMed ID: 17294233
[TBL] [Abstract][Full Text] [Related]
34. Kallikreins and proteinase-mediated signaling: proteinase-activated receptors (PARs) and the pathophysiology of inflammatory diseases and cancer.
Hollenberg MD; Oikonomopoulou K; Hansen KK; Saifeddine M; Ramachandran R; Diamandis EP
Biol Chem; 2008 Jun; 389(6):643-51. PubMed ID: 18627296
[TBL] [Abstract][Full Text] [Related]
35. Biased signalling and proteinase-activated receptors (PARs): targeting inflammatory disease.
Hollenberg MD; Mihara K; Polley D; Suen JY; Han A; Fairlie DP; Ramachandran R
Br J Pharmacol; 2014 Mar; 171(5):1180-94. PubMed ID: 24354792
[TBL] [Abstract][Full Text] [Related]
36. Proteinase-activated receptors (PARs): crossroads between innate immunity and coagulation.
Cirino G; Vergnolle N
Curr Opin Pharmacol; 2006 Aug; 6(4):428-34. PubMed ID: 16777485
[TBL] [Abstract][Full Text] [Related]
37. Homeostatic effects of coagulation protease-dependent signaling and protease activated receptors.
Isermann B
J Thromb Haemost; 2017 Jul; 15(7):1273-1284. PubMed ID: 28671351
[TBL] [Abstract][Full Text] [Related]
38. The Role of Protease-Activated Receptors for the Development of Myocarditis: Possible Therapeutic Implications.
Weithauser A; Witkowski M; Rauch U
Curr Pharm Des; 2016; 22(4):472-84. PubMed ID: 26696253
[TBL] [Abstract][Full Text] [Related]
39. Emerging Roles of Protease-Activated Receptors (PARs) in the Modulation of Synaptic Transmission and Plasticity.
Price R; Mercuri NB; Ledonne A
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33467143
[TBL] [Abstract][Full Text] [Related]
40. Protease-activated receptors as drug targets in inflammation and pain.
Vergnolle N
Pharmacol Ther; 2009 Sep; 123(3):292-309. PubMed ID: 19481569
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
